Skip to main content
. Author manuscript; available in PMC: 2022 Apr 7.
Published in final edited form as: Nature. 2021 Apr 7;592(7855):611–615. doi: 10.1038/s41586-021-03440-3

Extended Data Table 1.

MIC of the resistant staphylococci obtained after activation of the type III-A CRISPR-Cas immune response.

MIC (μg/ml) regular colonies MIC (μg/ml) resistant colonies
rifampicin 0.004–0.008 >0.256
gentamicin 1–2 16–32
vancomycin 2.0 16.0
levofloxacin 0.125 1.0